每日投资策略-20251204

Group 1: Market Overview - Global markets showed mixed performance, with the Hang Seng Index closing at 25,761, down 1.28% for the day but up 28.42% year-to-date [1] - The US markets saw gains, with the Dow Jones up 0.86% and the S&P 500 up 0.30%, while the Nasdaq increased by 0.17% [1] - The Chinese stock market experienced declines, particularly in healthcare, consumer discretionary, and financial sectors, while materials and utilities outperformed [3] Group 2: Economic Outlook - The global economic outlook for 2026 suggests resilience due to inventory demand, AI trends, and fiscal expansion, despite challenges from tariffs [5] - The US GDP growth is projected to decrease from 1.9% in 2025 to 1.8% in 2026, with a cooling job market and rising unemployment rates [6] - The Eurozone GDP growth is expected to decline from 1.4% in 2025 to 1.2% in 2026, influenced by tightening financial conditions and slowing global trade [6] Group 3: Company Analysis - The report highlights that 巨子生物 (Giant Bio) is facing short-term sales pressure due to underperformance in its sales channels, but management remains focused on strategic adjustments [9] - The company plans to enhance its self-operated channels and reduce reliance on top influencers, aiming for long-term growth despite current competitive pressures [9] - The company has been approved to repurchase up to 10% of its shares, reflecting confidence in its long-term prospects [10]